TechFlow, August 7 — Processa Pharmaceuticals (Nasdaq: PCSA) today announced a strategic investment and plans to incorporate cryptocurrency into its corporate treasury management strategy. The company has engaged LifeSci Capital as an advisor to assist in implementing the related strategy.
Processa stated that this decision aims to diversify its capital structure and enhance financial flexibility. The company will explore using blockchain assets to support its clinical development programs, strictly adhering to regulatory standards.




